ArticleiScience2025

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

Petros Kechagioglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.